Please Wait.....
Report
NA Drug modeling software Market - Industry Trends and Forecast to 2030
Market Report I 2023-06-01 I 214 Pages I Data Bridge Market Research
The drug modeling software market is expected to reach USD 16,808.81 million by 2030 from USD 8,504.35 million in 2022, growing at a CAGR of 9.2% during the forecast period of 2023 to 2033.
Market Segmentation:
North America Drug Modeling Software Market, By Component (Software, and Services), Operating System (Windows, Linux, Mac OS, and Others), Deployment Mode (Cloud Based, Hybrid Based, and On Premises), Enterprise Size(Large Enterprise Size, Small and Medium Enterprise Size), Application (Graphical Molecular Modeling, Gene Sequence Analysis, Protein Modeling, Modeling Crystal Structures, Cheminformatics, High Throughput Virtual Screening, Gas and Solution Phase Reaction, Medical Imaging, and Others), Purchase Model (Subscription Based, and One- Time License), End User( Pharmaceutical and Biotechnology Companies, Contract Research Organization, Research Institutes, Regulatory Authorities, and Others), Country ( U.S., Canada, Mexico)- Industry Trends and Forecast to 2030
Overview of the Drug Modeling Software Market Dynamics :
Driver
- Rising drug discovery and development activities
Restrain
- Lack of quality data base
Opportunity
- Cloud computing and big data analytics in drug modelling
Market Players:
The key market players operating in the drug modeling software market are listed below:
- Dotmatics
- BC Platforms
- InSilicoTrials Technologies.
- VeriSIM Life., Atomwise Inc.
- Certara, USA.
- GENECODE
- Cresset., and Nanome Inc.
- SIMULATIONS PLUS.
- Dassault Systemes
- Scripps Research
- XtalPi Inc.
- Xybion
- ArgusLab
- Schrodinger, Inc.
TABLE OF CONTENTS
1 INTRODUCTION 57
1.1 OBJECTIVES OF THE STUDY 57
1.2 MARKET DEFINITION 57
1.3 OVERVIEW OF THE NORTH AMERICA DRUG MODELING SOFTWARE MARKET 57
1.4 CURRENCY AND PRICING 59
1.5 LIMITATIONS 59
1.6 MARKETS COVERED 59
2 MARKET SEGMENTATION 62
2.1 MARKETS COVERED 62
2.2 GEOGRAPHICAL SCOPE 63
2.3 YEARS CONSIDERED FOR THE STUDY 64
2.4 DBMR TRIPOD DATA VALIDATION MODEL 65
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 68
2.6 MULTIVARIATE MODELING 69
2.7 COMPONENT LIFELINE CURVE 69
2.8 DBMR MARKET POSITION GRID 70
2.9 VENDOR SHARE ANALYSIS 71
2.10 MARKET APPLICATION COVERAGE GRID 72
2.11 SECONDARY SOURCES 73
2.12 ASSUMPTIONS 73
3 EXECUTIVE SUMMARY 74
3.1 PORTER'S FIVE FORCES MODEL 78
3.2 VALUE CHAIN ANALYSIS 79
3.3 REGULATORY STANDARDS 80
3.4 TECHNOLOGICAL TRENDS 81
3.5 BENEFITS OF DRUG MODELING SOFTWARE 82
4 MARKET OVERVIEW 83
4.1 DRIVERS 85
4.1.1 RISING DRUG DISCOVERY AND DEVELOPMENT ACTIVITIES 85
4.1.2 RISING DEMAND FOR NOVEL THERAPIES 87
4.1.3 PRECISION MEDICINE AND INTERVENTION OF AI IN DRUG MODELLING 88
4.2 RESTRAINTS 89
4.2.1 LACK OF QUALITY DATA BASE 89
4.2.2 HIGH COST OF MANUFACTURING OF DRUG MODELLING SOFTWARE 89
4.3 OPPORTUNITIES 90
4.3.1 CLOUD COMPUTING AND BIG DATA ANALYTICS IN DRUG MODELLING 90
4.3.2 INCREASING ADOPTION OF MODELLING TOOLS IN DRUG DISCOVERY 91
4.4 CHALLENGES 91
4.4.1 LACK OF PROCEDURE FOR MULTI-DRUG EFFECT ASSESMENT 91
4.4.2 CHALLENGES WITH MODEL INTERPRETATION 92
5 NORTH AMERICA DRUG MODELING SOFTWARE MARKET, BY COMPONENTS 93
5.1 OVERVIEW 94
5.1.1 SOFTWARE 97
5.1.1.1 INTEGRATED 98
5.1.1.2 STANDALONE 98
5.1.1.3 LIGAND BASED 98
5.1.1.4 STRUCTURE BASED 98
5.2 SERVICES 98
5.2.1 PROFESSIONAL SERVICES 99
5.2.1.1 CONSULTING AND TRAINING 100
5.2.1.2 INTEGRATION AND IMPLEMENTATION 100
5.2.1.3 SUPPORT AND MAINTENANCE 100
5.2.2 MANAGED SERVICES 100
6 NORTH AMERICA DRUG MODELING SOFTWARE MARKET, BY OPERATING SYSTEM 101
6.1 OVERVIEW 102
6.2 WINDOWS 105
6.3 LINUX 105
6.4 MAC OS 106
6.5 OTHERS 107
7 NORTH AMERICA DRUG MODELING SOFTWARE MARKET, BY DEPLOYMENT MODE 108
7.1 OVERVIEW 109
7.2 CLOUD BASED 112
7.3 HYBRID-BASED 112
7.4 ON-PREMISES 113
8 NORTH AMERICA DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE 114
8.1 OVERVIEW 115
8.2 LARGE ENTERPRISE SIZE 118
8.3 SMALL & MEDIUM ENTERPRISE SIZE 118
9 NORTH AMERICA DRUG MODELING SOFTWARE MARKET, BY APPLICATION 120
9.1 OVERVIEW 121
9.2 GRAPHICAL MOLECULAR MODELING 124
9.3 GENE SEQUENCE ANALYSIS 124
9.4 PROTEIN MODELING 125
9.5 MODELING CRYSTAL STRUCTURES 126
9.6 CHEMINFORMATICS 127
9.7 HIGH THROUGHPUT VIRTUAL SCREENING 128
9.8 GAS & SOLUTION PHASE REACTION 128
9.9 MEDICAL IMAGING 129
9.10 OTHERS 130
10 NORTH AMERICA DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL 131
10.1 OVERVIEW 132
10.2 SUBSCRIPTION BASED 135
10.2.1 ANNUALLY SUBSCRIPTION 136
10.2.2 MONTHLY SUBSCRIPTION 136
10.3 ONE-TIME LICENSE 136
10.3.1 GROUP LICENSE 137
10.3.2 DESKTOP LICENSE 137
10.3.3 OTHERS 137
11 NORTH AMERICA DRUG MODELING SOFTWARE MARKET, BY END USER 138
11.1 OVERVIEW 139
11.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 142
11.2.1 LARGE ENTERPRISE SIZE 143
11.2.2 SMALL & MEDIUM ENTERPRISE SIZE 143
11.3 CONTRACT RESEARCH ORGANIZATIONS 143
11.3.1 LARGE ENTERPRISE SIZE 144
11.3.2 SMALL & MEDIUM ENTERPRISE SIZE 144
11.4 RESEARCH INSTITUTES 144
11.4.1 LARGE ENTERPRISE SIZE 145
11.4.2 SMALL & MEDIUM ENTERPRISE SIZE 145
11.5 REGULATORY AUTHORITIES 145
11.5.1 LARGE ENTERPRISE SIZE 146
11.5.2 SMALL & MEDIUM ENTERPRISE SIZE 147
11.6 OTHERS 147
11.6.1 LARGE ENTERPRISE SIZE 148
11.6.2 SMALL & MEDIUM ENTERPRISE SIZE 148
12 NORTH AMERICA DRUG MODELING SOFTWARE MARKET, BY REGION 149
12.1 NORTH AMERICA 150
12.1.1 U.S. 160
12.1.2 CANADA 165
12.1.3 MEXICO 170
13 NORTH AMERICA DRUG MODELING SOFTWARE MARKET: COMPANY LANDSCAPE 175
13.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 175
14 SWOT ANALYSIS 176
15 NORTH AMERICA DRUG MODELING SOFTWARE MARKET, COMPANY PROFILE 177
15.1 DASSAULT SYSTEMES 177
15.1.1 COMPANY SNAPSHOT 177
15.1.2 REVENUE ANALYSIS 177
15.1.3 COMPANY SHARE ANALYSIS 178
15.1.4 PRODUCT PORTFOLIO 178
15.1.5 RECENT DEVELOPMENT 178
15.2 AMAZON WEB SERVICES, INC. OR ITS AFFILIATES.(A SUBSIDIARY OF AMAZON) 179
15.2.1 COMPANY SNAPSHOT 179
15.2.2 REVENUE ANALYSIS 179
15.2.3 COMPANY SHARE ANALYSIS 180
15.2.4 PRODUCT PORTFOLIO 180
15.2.5 RECENT DEVELOPMENTS 180
15.3 CERTARA, USA. 181
15.3.1 COMPANY SNAPSHOT 181
15.3.2 REVENUE ANALYSIS 181
15.3.3 COMPANY SHARE ANALYSIS 182
15.3.4 PRODUCT PORTFOLIO 182
15.3.5 RECENT DEVELOPMENTS 182
15.4 SCHRODINGER, INC. 183
15.4.1 COMPANY SNAPSHOT 183
15.4.2 REVENUE ANALYSIS 183
15.4.3 COMPANY SHARE ANALYSIS 184
15.4.4 PRODUCT PORTFOLIO 184
15.4.5 RECENT DEVELOPMENT 184
15.5 CRESSET. 185
15.5.1 COMPANY SNAPSHOT 185
15.5.2 COMPANY SHARE ANALYSIS 185
15.5.3 PRODUCT PORTFOLIO 186
15.5.4 RECENT DEVELOPMENTS 186
15.6 ACELLERA LTD 187
15.6.1 COMPANY SNAPSHOT 187
15.6.2 PRODUCT PORTFOLIO 187
15.6.3 RECENT DEVELOPMENTS 187
15.7 ARGUSLAB 188
15.7.1 COMPANY SNAPSHOT 188
15.7.2 PRODUCT PORTFOLIO 188
15.7.3 RECENT DEVELOPMENT 188
15.8 ATOMWISE INC. 189
15.8.1 COMPANY SNAPSHOT 189
15.8.2 PRODUCT PORTFOLIO 189
15.8.3 RECENT DEVELOPMENT 189
15.9 BC PLATFORMS 190
15.9.1 COMPANY SNAPSHOT 190
15.9.2 PRODUCT PORTFOLIO 190
15.9.3 RECENT DEVELOPMENTS 191
15.10 BIOSOLVEIT GMBH 192
15.10.1 COMPANY SNAPSHOT 192
15.10.2 PRODUCT PORTFOLIO 192
15.10.3 RECENT DEVELOPMENT 192
15.11 DOTMATICS 193
15.11.1 COMPANY SNAPSHOT 193
15.11.2 PRODUCT PORTFOLIO 193
15.11.3 RECENT DEVELOPMENTS 194
15.12 GENECODE 195
15.12.1 COMPANY SNAPSHOT 195
15.12.2 PRODUCT PORTFOLIO 195
15.12.3 RECENT DEVELOPMENT 195
15.13 INSILICOTRIALS TECHNOLOGIES. 196
15.13.1 COMPANY SNAPSHOT 196
15.13.2 PRODUCT PORTFOLIO 196
15.13.3 RECENT DEVELOPMENTS 197
15.14 NANOME INC. 198
15.14.1 COMPANY SNAPSHOT 198
15.14.2 PRODUCT PORTFOLIO 198
15.14.3 RECENT DEVELOPMENT 198
15.15 OPTIBRIUM, LTD. 199
15.15.1 COMPANY SNAPSHOT 199
15.15.2 PRODUCT PORTFOLIO 199
15.15.3 RECENT DEVELOPMENT 199
15.16 PHARMACELERA 200
15.16.1 COMPANY SNAPSHOT 200
15.16.2 PRODUCT PORTFOLIO 200
15.16.3 RECENT DEVELOPMENT 200
15.17 SIMULATIONS PLUS. 201
15.17.1 COMPANY SNAPSHOT 201
15.17.2 REVENUE ANALYSIS 202
15.17.3 COMPANY SHARE ANALYSIS 203
15.17.4 PRODUCT PORTFOLIO 203
15.17.5 RECENT DEVELOPMENT 204
15.18 THE SCRIPPS RESEARCH INSTITUTE 205
15.18.1 COMPANY SNAPSHOT 205
15.18.2 PRODUCT PORTFOLIO 205
15.18.3 RECENT DEVELOPMENT 205
15.19 VERISIM LIFE. 206
15.19.1 COMPANY SNAPSHOT 206
15.19.2 PRODUCT PORTFOLIO 206
15.19.3 RECENT DEVELOPMENTS 206
15.20 XTALPI INC. 207
15.20.1 COMPANY SNAPSHOT 207
15.20.2 PRODUCT PORTFOLIO 207
15.20.3 RECENT DEVELOPMENT 207
15.21 XYBION DIGITAL INC. 208
15.21.1 COMPANY SNAPSHOT 208
15.21.2 REVENUE ANALYSIS 208
15.21.3 PRODUCT PORTFOLIO 209
15.21.4 RECENT DEVELOPMENT 209
16 QUESTIONNAIRE 210
17 RELATED REPORTS 214
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security